[Other] Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial |
|
This post will be closed automatically in 2026-06-19 03:28
Best Answer
1 hour(s) ago
|
| |
20
Development of an OpenFOAM-Based Magnetohydrodynamic Solver for Magnetic Nozzle Simulations
20
Clinical study of total ankle replacement with gait analysis. A preliminary report.
30
The Use of POGIL Teaching Strategy Increases Student Learning of Basic Pharmacology Concepts
20
Green synthesis of silver nanoparticles using Calathea ornata extract: Characterization, antimicrobial properties, and cytotoxicity assessment
20
Intravenous VasoCT for the Follow-Up of Intracranial Aneurysms Treated with Flow-Diverter Stents: Feasibility and Exploratory Correlation with DSA
